Valneva SE (XTER:AYJ) Research & Development: €85.6 Mil (TTM As of Mar. 2026)


XTER:AYJ Valneva SE XTER:AYJ
59 GF Score
Price €2.23
GF Value €2.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE Research & Development?

Valneva SE XTER:AYJ +3.48% 59 Research & Development is €85.6 Mil as of Mar. 2026. GuruFocus rates XTER:AYJ with a GF Score™ of 59/100 and a GF Value™ of €2.46 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Valneva SE's Research & Development for the three months ended in Mar. 2026 was €15.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €85.6 Mil.

Valneva SE  (XTER:AYJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Valneva SE Research & Development Related Terms

Valneva SE Research & Development Historical Data

* Premium members only.

The historical data trend for Valneva SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valneva SE Research & Development Chart

Valneva SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.28 104.92 59.89 74.14 85.30

Valneva SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.95 17.49 27.29 25.57 15.22
XTER:AYJ
59GF Score
Valneva SE XTER:AYJ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valneva SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €85.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €85.6 Mil mean?
Valneva SE (XTER:AYJ) has a Research & Development of €85.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Valneva SE and its competitors.
Is Valneva SE's Research & Development too high?
Valneva SE's current Research & Development is €85.6 Mil. Overall, Valneva SE has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valneva SE's Research & Development compare to VRTX and REGN?
Valneva SE's Research & Development of €85.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Valneva SE and its competitors. Valneva SE's current Research & Development is €85.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valneva SE stock overvalued right now?
Based on GuruFocus' analysis, Valneva SE (XTER:AYJ) is currently considered Fairly Valued. The stock's GF Value™ is €2.46, compared to a current price of €2.23 — trading 9.3% below its estimated fair value. The current Research & Development is €85.6 Mil. Valneva SE's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Valneva SE (XTER:AYJ), the current Research & Development is €85.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valneva SE (XTER:AYJ) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.23 is trading 9.3% below its estimated GF Value™ of €2.46. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for XTER:AYJ:

  • Research & Development: €85.6 Mil
  • GF Value™: €2.46 vs. price of €2.23 (9.3% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the XTER:AYJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
59GF Score

Get the complete analysis for XTER:AYJ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.23
Price
€2.46
GF Value